Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study
Bernardo Alfonso Martínez-Guerra, María Fernanda González-Lara, Carla M. Román‐Montes, Karla M. Tamez‐Torres, Francisco Eduardo Dardón-Fierro, Sandra Rajme‐López, Carla Medrano-Borromeo, Alejandra Martínez-Valenzuela, Edgar Ortíz‐Brizuela, José Sifuentes‐Osornio, Alfredo Ponce‐de‐León
Abstract
< .01). Treatment with corticosteroids was associated with reduced in-hospital mortality among patients with severe and critical COVID-19, including those on IMV.
Topics & Concepts
MedicinePropensity score matchingInternal medicineDexamethasoneMechanical ventilationMultivariate analysisCoronavirus disease 2019 (COVID-19)Cohort studyCohortProspective cohort studyMortality rateDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Respiratory Support and Mechanisms